Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

High Risk

Score: 75/100

Failure Rate

17.4%

4 terminated/withdrawn out of 23 trials

Success Rate

66.7%

-19.8% vs industry average

Late-Stage Pipeline

0 trials in Phase 3/4

Results Transparency

38%

3 of 8 completed trials have results

Key Signals

3 with results

Enrollment Performance

Analytics

N/A

16(94.1%)

Phase 2

1(5.9%)

17Total

N/A(16)

Phase 2(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (23)

Showing 20 of 23 trials

NCT04502316Active Not Recruiting

Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence (REBALANCE Registry)

Role: lead

NCT07232030Not ApplicableEnrolling By Invitation

Barostim-Enabled NEurohormonal Intervention For Improving Treatment of Heart Failure

Role: lead

NCT02627196Not ApplicableCompleted

Baroreflex Activation Therapy for Heart Failure

Role: lead

NCT07335510Not ApplicableNot Yet Recruiting

Impact of Barostimulation on Hemodynamics in Adults With Heart Failure

Role: collaborator

NCT06195046Not ApplicableWithdrawn

Baroreflex Activation Therapy in Left Ventricular Assist Device Patients Study

Role: collaborator

NCT01471834Not ApplicableActive Not Recruiting

Verification of the Efficacy and Safety of the BAROSTIM NEO System in the Treatment of Drug Resistant Hypertension

Role: lead

NCT01679132Not ApplicableSuspended

BAROSTIM NEO Hypertension Pivotal Trial

Role: lead

NCT05860348Terminated

Symptomatic CRT Patients: Real-World Experience - Barostim™ Advancing the Level of Clinical Evidence

Role: lead

NCT04600791Not ApplicableTerminated

BATwire Implant Kit

Role: lead

NCT03730519Not ApplicableTerminated

UK Registry for Baroreflex Activation Therapy

Role: collaborator

NCT02880631Unknown

BAROSTIM THERAPY™ In Resistant Hypertension

Role: lead

NCT02880618Unknown

BAROSTIM THERAPY™ in Heart Failure With Reduced Ejection Fraction

Role: lead

NCT02876042Unknown

BAROSTIM THERAPY™ In Heart Failure With Preserved Ejection Fraction

Role: lead

NCT01484288Not ApplicableCompleted

Baroreflex Activation Therapy in Heart Failure

Role: lead

NCT00957073Not ApplicableCompleted

Rheos System for the Treatment of HFpEF Heart Failure

Role: lead

NCT01471860Not ApplicableUnknown

BAROSTIM NEO System in the Treatment of Heart Failure

Role: lead

NCT01077180Phase 2Completed

Rheos Feasibility Trial

Role: lead

NCT01720160Not ApplicableUnknown

BAROSTIM® Hope for Heart Failure Study

Role: lead

NCT00442286Not ApplicableCompleted

Rheos® Pivotal Trial

Role: lead

NCT00718939Not ApplicableCompleted

Rheos® Diastolic Heart Failure Trial

Role: lead